2025-2031 Global HMO Infant Formula Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Consumer Goods > 2025-2031 Global HMO Infant Formula Industry Research & Trends Analysis Report

2025-2031 Global HMO Infant Formula Industry Research & Trends Analysis Report

Publication Date: 2025-10-20
Report Id: 2559826
Industry: Consumer Goods
Report Page: 128
Chart: 127

PDF Download

Publication Date: 2025-10-20
Report Id: 2559826
Industry: Consumer Goods
Report Page: 128
Chart: 127

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 HMO Infant Formula Definition
1.2 Global HMO Infant Formula Market Size and Forecast
1.2.1 By Revenue, Global HMO Infant Formula Market Size, 2020-2031
1.2.2 By Sales Volume, Global HMO Infant Formula Market Size, 2020-2031
1.2.3 Global HMO Infant Formula Price Trend, 2020-2031
1.3 China HMO Infant Formula Market Size and Forecast
1.3.1 By Revenue, China HMO Infant Formula Market Size, 2020-2031
1.3.2 By Sales Volume, China HMO Infant Formula Market Size, 2020-2031
1.3.3 China HMO Infant Formula Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China HMO Infant Formula Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China HMO Infant Formula Share in Global Market, 2020-2031
1.4.3 HMO Infant Formula Market Size: China VS Global, 2020-2031
1.5 HMO Infant Formula Market Dynamics
1.5.1 HMO Infant Formula Market Drivers
1.5.2 HMO Infant Formula Market Restraints
1.5.3 HMO Infant Formula Industry Trends
1.5.4 HMO Infant Formula Industry Policy

2 Global Competitive Landscape by Company
2.1 Global HMO Infant Formula Revenue by Company, 2020-2025
2.2 Global HMO Infant Formula Sales Volume by Company, 2020-2025
2.3 Global HMO Infant Formula Price by Company, 2020-2025
2.4 Global HMO Infant Formula Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global HMO Infant Formula Concentration Ratio
2.6 Global HMO Infant Formula Mergers & Acquisitions, Expansion Plans
2.7 Global HMO Infant Formula Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China HMO Infant Formula Revenue by Company, 2020-2025
3.2 China HMO Infant Formula Sales Volume by Company, 2020-2025
3.3 China HMO Infant Formula HMO Infant Formula Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China HMO Infant Formula Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, HMO Infant Formula Domestic VS Export
3.6 China Market, HMO Infant Formula Import & Export
3.6.1 China Market, HMO Infant Formula Import & Export, 2020-2031
3.6.2 China HMO Infant Formula Import & Export Trends
3.6.3 Main Sources of China HMO Infant Formula Import
3.6.4 Export Destination of China HMO Infant Formula

4 HMO Infant Formula Production by Region
4.1 Global HMO Infant Formula Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of HMO Infant Formula Manufacturers
4.3 Global Major Manufacturers, HMO Infant Formula Capacity Expansion and Future Plans
4.4 Global HMO Infant Formula Capacity by Region
4.5 Global HMO Infant Formula Production by Region
4.5.1 Global HMO Infant Formula Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global HMO Infant Formula Production by Region, 2020-2025
4.5.3 Global HMO Infant Formula Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 HMO Infant Formula Industry Chain
5.2 HMO Infant Formula Upstream Analysis
5.2.1 HMO Infant Formula Core Raw Materials
5.2.2 Main Manufacturers of HMO Infant Formula Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 HMO Infant Formula Production Mode
5.6 HMO Infant Formula Procurement Model
5.7 HMO Infant Formula Industry Sales Model and Sales Channels
5.7.1 HMO Infant Formula Sales Model
5.7.2 HMO Infant Formula Typical Distributors

6 Sights by Product Type
6.1 HMO Infant Formula Classification
6.1.1 2'-Fucosyllactose (2'-FL)
6.1.2 Others
6.2 by Type, Global HMO Infant Formula Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global HMO Infant Formula Revenue, 2020-2031
6.4 by Type, Global HMO Infant Formula Sales Volume, 2020-2031
6.5 by Type, Global HMO Infant Formula Price, 2020-2031

7 Sights by Sales Channel
7.1 HMO Infant Formula Segment by Sales Channel
7.1.1 Online Channel
7.1.2 Specialty Store
7.1.3 Supermarket
7.1.4 Others
7.2 by Sales Channel, Global HMO Infant Formula Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Sales Channel, Global HMO Infant Formula Revenue, 2020-2031
7.4 by Sales Channel, Global HMO Infant Formula Sales Volume, 2020-2031
7.5 by Sales Channel, Global HMO Infant Formula Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global HMO Infant Formula Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global HMO Infant Formula Revenue, 2020-2031
8.3 By Region, Global HMO Infant Formula Sales Volume, 2020-2031
8.4 North America
8.4.1 North America HMO Infant Formula Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America HMO Infant Formula Market Size Market Share
8.5 Europe
8.5.1 Europe HMO Infant Formula Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe HMO Infant Formula Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific HMO Infant Formula Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific HMO Infant Formula Market Size Market Share
8.7 South America
8.7.1 South AmericaHMO Infant Formula Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America HMO Infant Formula Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global HMO Infant Formula Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global HMO Infant Formula Revenue, 2020-2031
9.3 By Country, Global HMO Infant Formula Sales Volume, 2020-2031
9.4 United States
9.4.1 United States HMO Infant Formula Market Size, 2020-2031
9.4.2 By Company, United States HMO Infant Formula Sales Volume Market Share, 2024
9.4.3 by Type, United States HMO Infant Formula Market Size, Share, 2024 VS 2031
9.4.4 by Sales Channel, United States HMO Infant Formula Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe HMO Infant Formula Market Size, 2020-2031
9.5.2 By Company, Europe HMO Infant Formula Sales Volume Market Share, 2024
9.5.3 by Type, Europe HMO Infant Formula Market Size, Share, 2024 VS 2031
9.5.4 by Sales Channel, Europe HMO Infant Formula Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China HMO Infant Formula Market Size, 2020-2031
9.6.2 By Company, China HMO Infant Formula Sales Volume Market Share, 2024
9.6.3 by Type, China HMO Infant Formula Market Size, Share, 2024 VS 2031
9.6.4 by Sales Channel, China HMO Infant Formula Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan HMO Infant Formula Market Size, 2020-2031
9.7.2 By Company, Japan HMO Infant Formula Market Share, 2024
9.7.3 by Type, Japan HMO Infant Formula Market Size, Share, 2024 VS 2031
9.7.4 by Sales Channel, Japan HMO Infant Formula Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea HMO Infant Formula Market Size, 2020-2031
9.8.2 By Company, South Korea HMO Infant Formula Market Share, 2024
9.8.3 by Type, South Korea HMO Infant Formula Market Size, Share, 2024 VS 2031
9.8.4 by Sales Channel, South Korea HMO Infant Formula Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia HMO Infant Formula Market Size, 2020-2031
9.9.2 By Company, Southeast Asia HMO Infant Formula Market Share, 2024
9.9.3 by Type, Southeast Asia HMO Infant Formula Market Size, Share, 2024 VS 2031
9.9.4 by Sales Channel, Southeast Asia HMO Infant Formula Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India HMO Infant Formula Market Size, 2020-2031
9.10.2 By Company, India HMO Infant Formula Market Share, 2024
9.10.3 by Type, India HMO Infant Formula Market Size, Share, 2024 VS 2031
9.10.4 by Sales Channel, India HMO Infant Formula Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa HMO Infant Formula Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa HMO Infant Formula Market Share, 2024
9.11.3 by Type, Middle East & Africa HMO Infant Formula Market Size, Share, 2024 VS 2031
9.11.4 by Sales Channel, Middle East & Africa HMO Infant Formula Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Abbott
10.1.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abbott HMO Infant Formula Models, Specifications, and Application
10.1.3 Abbott HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Abbott Company Profile and Main Business
10.1.5 Abbott Recent Developments
10.2 Mead Johnson（Reckitt）
10.2.1 Mead Johnson（Reckitt） Company Information, Head Office, Market Area, and Industry Position
10.2.2 Mead Johnson（Reckitt） HMO Infant Formula Models, Specifications, and Application
10.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Mead Johnson（Reckitt） Company Profile and Main Business
10.2.5 Mead Johnson（Reckitt） Recent Developments
10.3 Nestlé（Wyeth Nutrition）
10.3.1 Nestlé（Wyeth Nutrition） Company Information, Head Office, Market Area, and Industry Position
10.3.2 Nestlé（Wyeth Nutrition） HMO Infant Formula Models, Specifications, and Application
10.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Nestlé（Wyeth Nutrition） Company Profile and Main Business
10.3.5 Nestlé（Wyeth Nutrition） Recent Developments
10.4 Danone (Aptamil)
10.4.1 Danone (Aptamil) Company Information, Head Office, Market Area, and Industry Position
10.4.2 Danone (Aptamil) HMO Infant Formula Models, Specifications, and Application
10.4.3 Danone (Aptamil) HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Danone (Aptamil) Company Profile and Main Business
10.4.5 Danone (Aptamil) Recent Developments
10.5 FrieslandCampina (Friso)
10.5.1 FrieslandCampina (Friso) Company Information, Head Office, Market Area, and Industry Position
10.5.2 FrieslandCampina (Friso) HMO Infant Formula Models, Specifications, and Application
10.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 FrieslandCampina (Friso) Company Profile and Main Business
10.5.5 FrieslandCampina (Friso) Recent Developments
10.6 Biostime
10.6.1 Biostime Company Information, Head Office, Market Area, and Industry Position
10.6.2 Biostime HMO Infant Formula Models, Specifications, and Application
10.6.3 Biostime HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Biostime Company Profile and Main Business
10.6.5 Biostime Recent Developments
10.7 Yili Group (Ausnutria Dairy)
10.7.1 Yili Group (Ausnutria Dairy) Company Information, Head Office, Market Area, and Industry Position
10.7.2 Yili Group (Ausnutria Dairy) HMO Infant Formula Models, Specifications, and Application
10.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Yili Group (Ausnutria Dairy) Company Profile and Main Business
10.7.5 Yili Group (Ausnutria Dairy) Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for HMO Infant Formula should grow from US$ 4104 million in 2024 to US$ 8051 million by 2031, with a CAGR of 10.2% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

HMO Infant Formula

According to YH Research, the global market for HMO Infant Formula should grow from US$ 4104 million in 2024 to US$ 8051 million by 2031, with a CAGR of 10.2% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.

Global key players of HMO Infant Formula include Nestlé (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.

This report aims to provide a comprehensive study of the global market for HMO Infant Formula.
Report Highlights:
(1) Global HMO Infant Formula market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global HMO Infant Formula market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China HMO Infant Formula market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global HMO Infant Formula segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global HMO Infant Formula segment by Type, and by Sales Channel, and regional segment by Type, and by Sales Channel.

(6) Global major production regions of HMO Infant Formula, capacity, production and trends.

(7) HMO Infant Formula industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
2'-Fucosyllactose (2'-FL)
Others

Market segment by Sales Channel, can be divided into
Online Channel
Specialty Store
Supermarket
Others

Market segment by players, this report covers
Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)